Changes in the prevalence of maternal chronic conditions during pregnancy: A nationwide age–period–cohort analysis

Abstract

AbstractObjectiveTo estimate temporal changes in the prevalence of pre‐existing chronic conditions among pregnant women in Sweden and evaluate the extent to which secular changes in maternal age, birth cohorts and obesity are associated with these trends.DesignPopulation‐based cross‐sectional study.SettingSweden, 2002–2019.PopulationAll women (aged 15–49 years) who delivered in Sweden (2002–2019).MethodsAn age–period–cohort analysis was used to evaluate the effects of age, calendar periods, and birth cohorts on the observed temporal trends.Main outcome measuresPre‐existing chronic conditions, including 17 disease categories of physical and psychiatric health conditions recorded within 5 years before childbirth, presented as prevalence rates and rate ratios (RRs) with 95% confidence intervals (CIs). Temporal trends were also adjusted for pre‐pregnancy body mass index (BMI) and the mother's country of birth.ResultsThe overall prevalence of at least one pre‐existing chronic condition was 8.7% (147 458 of 1 703 731 women). The rates of pre‐existing chronic conditions in pregnancy increased threefold between 2002–2006 and 2016–2019 (RR 2.82, 95% CI 2.77–2.87). Rates of psychiatric (RR 3.80, 95% CI 3.71–3.89), circulatory/metabolic (RR 1.62, 95% CI 1.55–1.71), autoimmune/neurological (RR 1.69, 95% CI 1.61–1.78) and other (RR 2.10, 95% CI 1.99–2.22) conditions increased substantially from 2002–2006 to 2016–2019. However, these increasing rates were less pronounced between 2012–2015 and 2016–2019. No birth cohort effect was evident for any of the pre‐existing chronic conditions. Adjusting for secular changes in obesity and the mother's country of birth did not affect these associations.ConclusionsThe burden of pre‐existing chronic conditions in pregnancy in Sweden increased from 2002 to 2019. This increase may be associated with the improved reporting of diagnoses and advancements in chronic condition treatment among women, potentially enhancing their fecundity.